Yıl: 2020 Cilt: 31 Sayı: 5 Sayfa Aralığı: 393 - 399 Metin Dili: İngilizce DOI: 10.5152/tjg.2020.19913 İndeks Tarihi: 19-06-2021

Can family physicians have a role in eradication of hepatitis c infection?

Öz:
Background/Aims: Hepatitis C virus (HCV) infection is an important global public health problem. Application of screening programs is important for elimination of HCV in addition to direct-acting antiviral (DAA) therapies. In this study, we aimed to measure knowledge, attitudes, and behaviors of family physicians (FPs) who are important in screening programs regarding diagnosis, natural history, and treatment of HCV infection.Materials and Methods: This study was designed as a cross-sectional study, aiming at measuring HCV knowledge levels about screening, diagnosis, natural history, and treatment of FPs working nationwide in Turkey, through a survey.Results: The most common reason for the participants to perform anti-HCV test is the mandatory screening program before marriage by 70.9% (420). Of the participants included in the study, 29.6% (n=175) encountered anti-HCV test positivity at least once within the last 1 year. Of the physicians who encountered anti-HCV test positivity, 15.4% (n=27) had no knowledge about whether the patients went to a higher level center for further diagnosis, whereas 58.9% (n=103) did not know stage of the disease. Of participants, 14.5% (86) responded as DAA and 34.8% (206) responded as interferon + ribavirin treatment for hepatitis C infection.Conclusion: FPs have lack and gaps of knowledge regarding screening, natural history, and treatment of HCV infection. The results of this study show that HCV training plans for FPs should cover all aspects of the infection, and emphasize the necessity of guidelines-based screening recommendations.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61 Suppl 1: S45-57. [CrossRef]
  • 2. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol 2014; 61 Suppl 1: S58-68. [CrossRef]
  • 3. Lanini S, Easterbrook PJ, Zumla A, Ippolito G. Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect 2016; 22: 833-8. [CrossRef]
  • 4. World Health Organization. Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection. World Health Organization, 2016.
  • 5. Wedemeyer H, Duberg AS, Buti M, et al. Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat 2014; 21: 60-89. [CrossRef]
  • 6. Clark EC, Yawn BP, Galliher JM, Temte JL, Hickner J. Hepatitis C identification and management by family physicians. Fam Med 2005; 37: 644-9
  • 7. Samuel ST., Martinez AD, Chen Y, Markatou M, Talal AH. Hepatitis C virus knowledge improves hepatitis C virus screening practices among primary care physicians. World J Hepatol 2018; 10: 319-28. [CrossRef]
  • 8. Zickmund SL, Brown KE, Bielefeldt K. A systematic review of provider knowledge of hepatitis C: is it enough for a complex disease? Dig Dis Sci 2007; 52: 2550-6. [CrossRef]
  • 9. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep 2012; 61: 1-32.
  • 10. http://www3.kalkinma.gov.tr/DocObjects/View/15310/SEGE-2011.pdf (accesed time: 05.07.2019)
  • 11. Reau N. “HCV testing and linkage to care: expanding access. Clin Liver Dis (Hoboken) 2014; 4: 31-4. [CrossRef]
  • 12. Tozun N, Özdoğan O, Çakaloğlu Y, et al. “Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015; 21: 1020-6. [CrossRef]
  • 13. “ Turkey Viral Hepatitis Prevention and Control Program “Republic of Turkey Ministry of Health Publication No:1102, Ankara-2018.
  • 14. Shehab TM, Sonnad SS, Lok AS. Management of hepatitis C patients by primary care physicians in the USA: results of a national survey. J Viral Hepat 2001; 8: 377-83. [CrossRef]
  • 15. http://www.tuik.gov.tr/PreHaberBultenleri.do?id=27593 (Accessed on: 04 Mart 2019)
  • 16. Razavi H, Waked I, Sarrazin C, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat 2014; 21 Suppl 1: 34-59.
  • 17. Centers for Disease Control and Prevention (CDC). Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013; 62: 362-5.
  • 18. Ecemiş T, Akçalı S, Dündar PE, Şanlıdağ T. The Threshold Value of Anti-HCV Test in the Diagnosis of HCV Infection. Turkiye Klinikleri J Med Sci 2012; 32: 1648-52. [CrossRef]
  • 19. Anouk D, and Sievert W. A survey of Australian general practice management of hepatitis C- infected patients from non- English- speaking backgrounds. J Gastroenterol Hepatol 2002; 17: 295-300. [CrossRef]
  • 20. Falade-Nwulia O, McAdams-Mahmoud A, Irvin R, et al. Primary care providers knowledge, attitude and practices related to hepatitis C screening and treatment in the oral direct acting antiviral agents era. J Community Med Health Educ 2016; 6: 481. [CrossRef]
  • 21. Moorman AC, Gordon SC, Rupp LB, et al. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study. Clin Infect Dis 2013; 56: 40-50. [CrossRef]
  • 22. Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med 2013; 368:1859-1861. [CrossRef]
  • 23. Akarca US, Danis N, Altuglu I, et al. Anti-HCV screening before surgical procedures, to protect the surgical team or to detect new treatable patients” 20th ESCV 2017 oral presentation.
  • 24. Edlin BR. Access to treatment for hepatitis C virus infection: time to put patients first. Lancet Infect Dis 2016; 16: e196-201. [CrossRef]
APA Şahin A, Erdoğan A, gişi k, ISPIROGLU M, GÜLER S, Okyay R, NAZİK S, KANTARÇEKEN B (2020). Can family physicians have a role in eradication of hepatitis c infection?. , 393 - 399. 10.5152/tjg.2020.19913
Chicago Şahin Ahmet Rıza,Erdoğan Ayşegül,gişi kadir,ISPIROGLU MURAT,GÜLER Selma ATEŞ,Okyay Ramazan Azim,NAZİK SELÇUK,KANTARÇEKEN BÜLENT Can family physicians have a role in eradication of hepatitis c infection?. (2020): 393 - 399. 10.5152/tjg.2020.19913
MLA Şahin Ahmet Rıza,Erdoğan Ayşegül,gişi kadir,ISPIROGLU MURAT,GÜLER Selma ATEŞ,Okyay Ramazan Azim,NAZİK SELÇUK,KANTARÇEKEN BÜLENT Can family physicians have a role in eradication of hepatitis c infection?. , 2020, ss.393 - 399. 10.5152/tjg.2020.19913
AMA Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B Can family physicians have a role in eradication of hepatitis c infection?. . 2020; 393 - 399. 10.5152/tjg.2020.19913
Vancouver Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B Can family physicians have a role in eradication of hepatitis c infection?. . 2020; 393 - 399. 10.5152/tjg.2020.19913
IEEE Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B "Can family physicians have a role in eradication of hepatitis c infection?." , ss.393 - 399, 2020. 10.5152/tjg.2020.19913
ISNAD Şahin, Ahmet Rıza vd. "Can family physicians have a role in eradication of hepatitis c infection?". (2020), 393-399. https://doi.org/10.5152/tjg.2020.19913
APA Şahin A, Erdoğan A, gişi k, ISPIROGLU M, GÜLER S, Okyay R, NAZİK S, KANTARÇEKEN B (2020). Can family physicians have a role in eradication of hepatitis c infection?. Turkish Journal of Gastroenterology, 31(5), 393 - 399. 10.5152/tjg.2020.19913
Chicago Şahin Ahmet Rıza,Erdoğan Ayşegül,gişi kadir,ISPIROGLU MURAT,GÜLER Selma ATEŞ,Okyay Ramazan Azim,NAZİK SELÇUK,KANTARÇEKEN BÜLENT Can family physicians have a role in eradication of hepatitis c infection?. Turkish Journal of Gastroenterology 31, no.5 (2020): 393 - 399. 10.5152/tjg.2020.19913
MLA Şahin Ahmet Rıza,Erdoğan Ayşegül,gişi kadir,ISPIROGLU MURAT,GÜLER Selma ATEŞ,Okyay Ramazan Azim,NAZİK SELÇUK,KANTARÇEKEN BÜLENT Can family physicians have a role in eradication of hepatitis c infection?. Turkish Journal of Gastroenterology, vol.31, no.5, 2020, ss.393 - 399. 10.5152/tjg.2020.19913
AMA Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B Can family physicians have a role in eradication of hepatitis c infection?. Turkish Journal of Gastroenterology. 2020; 31(5): 393 - 399. 10.5152/tjg.2020.19913
Vancouver Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B Can family physicians have a role in eradication of hepatitis c infection?. Turkish Journal of Gastroenterology. 2020; 31(5): 393 - 399. 10.5152/tjg.2020.19913
IEEE Şahin A,Erdoğan A,gişi k,ISPIROGLU M,GÜLER S,Okyay R,NAZİK S,KANTARÇEKEN B "Can family physicians have a role in eradication of hepatitis c infection?." Turkish Journal of Gastroenterology, 31, ss.393 - 399, 2020. 10.5152/tjg.2020.19913
ISNAD Şahin, Ahmet Rıza vd. "Can family physicians have a role in eradication of hepatitis c infection?". Turkish Journal of Gastroenterology 31/5 (2020), 393-399. https://doi.org/10.5152/tjg.2020.19913